References
Balfour JA, McTavish D. Drugs 46: 1025–1054, 1993
Marble A, et al. In Speight TM (Ed.) Avery’s drug treatment, 3rd ed., pp. 528–548, ADIS Press, Auckland, 1987
Hiele M, et al. Dig Dis Sci 37: 1057–1064, 1992
Sakamoto N, et al. Yakuri Chiryo 17: 633–649, 1989
Spengler M, Catagay M. Diabetes Stoff 1: 218–222, 1992
Hanefield M, et al. Diabetes Care 14: 732–737, 1991
Goméz-Pérez FJ, et al. Rev Invest Clin 44: 77–83, 1992
Innerfield RJ, Coniff RF. Diabetes 39 (Suppl. 1): 211A, 1990
Rybka J, et al. Drug Invest 2: 264–267, 1990
Hoffman J. Münch Med Wochen 132: 487–490, 1990
Spengler M, et al. Hormone Metab Res 26 (Suppl.):50–51, 1992
Buchanan DR, et al. Eur J Clin Pharmacol 34: 51–53, 1988
McCulloch DK, et al. Diabetes Care 6: 483–487, 1983
Hollander P, Coniff RF. Diabetes 40 (Suppl. 1): 307A, 1991
Escobar-Jiménez F, et al. Med Clin (Barcelona) 100: 488–491, 1993
Austenat E. Endokrinol Stoff 12: 19–24, 1991
Marena S, et al. Diabetic Med 8: 674–678, 1991
Hollander P. Drugs 44 (Suppl. 2): 47–53, 1992
Scheen AJ, et al. Eur J Clin Invest 23 (Suppl. 1): A43, 1993
Rights and permissions
About this article
Cite this article
Acarbose: an effective adjunct in NIDDM. Drugs Ther. Perspect 3, 5–7 (1994). https://doi.org/10.2165/00042310-199403100-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199403100-00002